Keap1 Cancer Research Results
Keap1, Kelch-like ECH-associated protein 1: Click to Expand ⟱
| Source: |
| Type: |
Kelch-like ECH-associated protein 1 (Keap1) is a key regulator of the transcription factor Nrf2.
-In several tumor types, loss of Keap1 function (either due to gene mutations or low protein expression) results in unrestrained Nrf2 activity.
• Persistent Nrf2 activation is thought to:
- Provide tumor cells with enhanced protection against oxidative stress.
- Contribute to chemoresistance and radioresistance.
- Promote metabolic reprogramming that fuels tumor growth.
• Thus, in many cancers, altered Keap1 status can serve as an indicator of poor prognosis and has been investigated as a potential target for therapeutic intervention.
|
Scientific Papers found: Click to Expand⟱
| - |
Review, |
Var, |
NA |
|
|
|
- |
Review, |
Park, |
NA |
|
|
|
- |
Review, |
AD, |
NA |
|
|
|
AntiCan↑, *neuroP↑, *cardioP↑, *AntiBio↑, *BioAv↑, *toxicity↓, *BioAv↑, *motorD↑, *SOD↑, *Catalase↑, *Keap1↑, *MDA↓, *GSH↑, *IL1β↓, *IL6↓, *TNF-α↓, *iNOS↓, *COX2/PTGS2↓, *lipid-P↓, *Cyt‑c↓, *ROS↓, *MMP↑, *antiOx↑, *AChE↓, *Apoptosis↓, *BAX↓, *Casp3↓, *Bcl-2↑, *BACE/β-secretase↓, *BChE↓, *eff↑, *Aβ↓, *ATP↑, RadioS↑, Cyt‑c↑, Casp3↑, Casp8↑, Casp9↑, Apoptosis↑, PARP↑, BAX↑, BID↑, NF-kB↑, Fas↑, EGFR↑, TIMP2↑, XIAP↓, COX2/PTGS2↓, Bak↓, Bcl-2↓, P53↑, HER2/EBBR2↓, FGF↓, CEA↓, Akt↓, TumCCA↑, *Imm↑, *CD4+↑, *CD8+↑, *BBB↑, *Pain↓, *cardioP↑, *TBARS↓, *SOD↑, *Catalase↑, *GSH↑, *AntiBio↑, *AntiFungal↑, *GastroP↑, *RenoP↑, *creat↓, *uricA↓, *Inflam↓, *iNOS↓, *COX2/PTGS2↓, *TNF-α↓, *IL6↑, *MMP13↓,
| - |
Review, |
Var, |
NA |
|
|
|
- |
Review, |
AD, |
NA |
|
|
|
*BioAv↓, *neuroP↑, *BBB↑, *ROS↓, *Keap1↑, *NRF2↑, *Casp3↓, *SIRT3↑, *Rho↓, *ERK↓, *NF-kB↓, angioG↓, RAS↓, PI3K↓, Akt↓, mTOR↓, *memory↑, *Aβ↓, *PPARγ↑, *PGC-1α↑, NF-kB↓, Hif1a↓, VEGF↓, HO-1↓, FOXM1↓, p27/CDKN1B↑, P21↑, CDK2↓, CDK4↓, CDK6↓, cycD1/CCND1↓, Twist↓, MMP2↓, Rho↑, ROCK1↑, TumCMig↓, cFLIP↓, BMPs↑, OCR↑, ECAR↓, *AntiAg↑, *cardioP↑, *antiOx↑, *ROS↓, P-gp/ABCB1↓,
| - |
in-vitro, |
Pca, |
LNCaP |
|
|
|
- |
in-vitro, |
Pca, |
DU145 |
|
|
|
- |
in-vitro, |
Nor, |
PrEC |
|
|
|
- |
in-vivo, |
NA, |
NA |
|
|
|
ROS↑, NADPH↑, RadioS↑, radioP↑, Trx↓, *ox-Keap1↑, ox-Keap1↓, rd-Keap1↑, *NRF2↑, NRF2∅, NF-kB↓,
Showing Research Papers: 1 to 3 of 3
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 3
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress(tgid=1) ⓘ
HO-1↓, 1, ox-Keap1↓, 1, rd-Keap1↑, 1, NRF2∅, 1, ROS↑, 1, Trx↓, 1,
Mitochondria & Bioenergetics(tgid=3) ⓘ
OCR↑, 1,
Core Metabolism/Glycolysis(tgid=4) ⓘ
ECAR↓, 1, NADPH↑, 1,
Cell Death(tgid=5) ⓘ
Apoptosis↑, 1, Bak↓, 1, BAX↑, 1, Bcl-2↓, 1, BID↑, 1, Casp3↑, 1, Casp8↑, 1, Casp9↑, 1, cFLIP↓, 1, Cyt‑c↑, 1, Fas↑, 1, XIAP↓, 1,
Kinase & Signal Transduction(tgid=6) ⓘ
Akt↓, 2, EGFR↑, 1, HER2/EBBR2↓, 1, mTOR↓, 1, PI3K↓, 1, RAS↓, 1,
Transcription & Epigenetics(tgid=7) ⓘ
FOXM1↓, 1,
DNA Damage & Repair(tgid=10) ⓘ
P53↑, 1, PARP↑, 1,
Cell Cycle & Senescence(tgid=11) ⓘ
CDK2↓, 1, CDK4↓, 1, CDK6↓, 1, cycD1/CCND1↓, 1, P21↑, 1, p27/CDKN1B↑, 1, TumCCA↑, 1,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
BMPs↑, 1, FGF↓, 1,
Migration(tgid=13) ⓘ
MMP2↓, 1, Rho↑, 1, ROCK1↑, 1, TIMP2↑, 1, TumCMig↓, 1, Twist↓, 1,
Angiogenesis & Vasculature(tgid=14) ⓘ
angioG↓, 1, Hif1a↓, 1, VEGF↓, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
COX2/PTGS2↓, 1, NF-kB↓, 2, NF-kB↑, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
P-gp/ABCB1↓, 1, RadioS↑, 2,
Clinical Biomarkers(tgid=22) ⓘ
CEA↓, 1, EGFR↑, 1, FOXM1↓, 1, HER2/EBBR2↓, 1,
Functional Outcomes(tgid=23) ⓘ
AntiCan↑, 1, radioP↑, 1,
Total Targets: 59
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress(tgid=1) ⓘ
antiOx↑, 2, Catalase↑, 2, GSH↑, 2, Keap1↑, 2, ox-Keap1↑, 1, lipid-P↓, 1, MDA↓, 1, NRF2↑, 2, ROS↓, 3, SOD↑, 2, TBARS↓, 1, uricA↓, 1,
Mitochondria & Bioenergetics(tgid=3) ⓘ
PGC-1α↑, 1, SIRT3↑, 1,
Core Metabolism/Glycolysis(tgid=4) ⓘ
ATP↑, 1,
Cell Death(tgid=5) ⓘ
Apoptosis↓, 1, BAX↓, 1, Bcl-2↑, 1, Casp3↓, 2, Cyt‑c↓, 1, iNOS↓, 2,
Kinase & Signal Transduction(tgid=6) ⓘ
ERK↓, 1,
Migration(tgid=13) ⓘ
AntiAg↑, 1, MMP13↓, 1, Rho↓, 1,
Barriers & Transport(tgid=15) ⓘ
BBB↑, 2, GastroP↑, 1, MMP↑, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
CD4+↑, 1, CD8+↑, 1, COX2/PTGS2↓, 2, IL1β↓, 1, IL6↓, 1, IL6↑, 1, Imm↑, 1, Inflam↓, 1, NF-kB↓, 1, TNF-α↓, 2,
Synaptic & Neurotransmission(tgid=18) ⓘ
AChE↓, 1, BChE↓, 1,
Protein Aggregation(tgid=19) ⓘ
Aβ↓, 2, BACE/β-secretase↓, 1,
Hormonal & Nuclear Receptors(tgid=20) ⓘ
PPARγ↑, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
BioAv↓, 1, BioAv↑, 2, eff↑, 1,
Clinical Biomarkers(tgid=22) ⓘ
creat↓, 1, IL6↓, 1, IL6↑, 1,
Functional Outcomes(tgid=23) ⓘ
cardioP↑, 3, memory↑, 1, motorD↑, 1, neuroP↑, 2, Pain↓, 1, RenoP↑, 1, toxicity↓, 1,
Infection & Microbiome(tgid=24) ⓘ
AntiBio↑, 2, AntiFungal↑, 1,
Total Targets: 58
Scientific Paper Hit Count for: Keap1, Kelch-like ECH-associated protein 1
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:1 prod#:% Target#:1174 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid
Home Page